EBS - Emergent BioSolutions Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.63B
Enterprise Value 33.11B
Trailing P/E 31.80
Forward P/E 126.20
PEG Ratio (5 yr expected) 12.08
Price/Sales (ttm)5.15
Price/Book (mrq)3.80
Enterprise Value/Revenue 34.41
Enterprise Value/EBITDA 616.88

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018

Profitability

Profit Margin 14.19%
Operating Margin (ttm)19.11%

Management Effectiveness

Return on Assets (ttm)7.67%
Return on Equity (ttm)12.28%

Income Statement

Revenue (ttm)705.48M
Revenue Per Share (ttm)14.56
Quarterly Revenue Growth (yoy)16.20%
Gross Profit (ttm)267.78M
EBITDA 184.56M
Net Income Avi to Common (ttm)100.12M
Diluted EPS (ttm)2.24
Quarterly Earnings Growth (yoy)-37.60%

Balance Sheet

Total Cash (mrq)339.36M
Total Cash Per Share (mrq)6.66
Total Debt (mrq)13.49M
Total Debt/Equity (mrq)1.40
Current Ratio (mrq)5.52
Book Value Per Share (mrq)18.76

Cash Flow Statement

Operating Cash Flow (ttm)285.09M
Levered Free Cash Flow (ttm)106.49M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.43
52-Week Change 378.88%
S&P500 52-Week Change 35.73%
52 Week High 371.77
52 Week Low 337.13
50-Day Moving Average 364.03
200-Day Moving Average 357.68

Share Statistics

Avg Vol (3 month) 3374.8k
Avg Vol (10 day) 3363.52k
Shares Outstanding 550.95M
Float 43.27M
% Held by Insiders 115.01%
% Held by Institutions 186.68%
Shares Short (Oct 31, 2018) 41.79M
Short Ratio (Oct 31, 2018) 45.73
Short % of Float (Oct 31, 2018) 44.26%
Short % of Shares Outstanding (Oct 31, 2018) 43.52%
Shares Short (prior month Sep 28, 2018) 41.99M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A